Good HIV disease control was achieved in @ % of the patients ( mean , @ patients ) in the NRTI group , @ % of the patients ( mean , @ ) in the raltegravir group ( P = @ for the comparison with the NRTI group ; superiority of raltegravir not shown ) , and @ % of the patients ( mean , @ ) in the monotherapy group ( noninferiority of monotherapy not shown , based on a @-percentage-point margin ) .